The role of civil society in protecting public health over commercial interests: lessons from Thailand.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D003132:Commerce / Q000331:legislation & jurisprudence*; D016049:Didanosine / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006801:Humans; D018973:Intellectual Property; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D028701:Patient Rights / Q000331:legislation & jurisprudence; D011635:Public Health Administration; D013785:Thailand / Q000453:epidemiology
D019380:Anti-HIV Agents; D016049:Didanosine
Health Care and Public Health; Legal Approach